Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsIn each bladder cancer organoid strain, epidermal growth factor receptor/ERK signaling was upregulated compared with normal bladder cells.
[Cancer Biology & Therapy]
6445212 GP2GMVYF items 1 apa 0 default asc 1 162730 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-2e39310f48e637871656f68ea1aa620c%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22GP2GMVYF%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Elbadawy%20et%20al.%22%2C%22parsedDate%22%3A%222021-05-26%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EElbadawy%2C%20M.%2C%20Sato%2C%20Y.%2C%20Mori%2C%20T.%2C%20Goto%2C%20Y.%2C%20Hayashi%2C%20K.%2C%20Yamanaka%2C%20M.%2C%20Azakami%2C%20D.%2C%20Uchide%2C%20T.%2C%20Fukushima%2C%20R.%2C%20Yoshida%2C%20T.%2C%20Shibutani%2C%20M.%2C%20Kobayashi%2C%20M.%2C%20Shinohara%2C%20Y.%2C%20Abugomaa%2C%20A.%2C%20Kaneda%2C%20M.%2C%20Yamawaki%2C%20H.%2C%20Usui%2C%20T.%2C%20%26amp%3B%20Sasaki%2C%20K.%20%282021%29.%20Anti-tumor%20effect%20of%20trametinib%20in%20bladder%20cancer%20organoid%20and%20the%20underlying%20mechanism.%20%3Ci%3ECancer%20Biology%20%26amp%3B%20Therapy%3C%5C%2Fi%3E%2C%20%3Ci%3E0%3C%5C%2Fi%3E%280%29%2C%201%26%23x2013%3B15.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F15384047.2021.1919004%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F15384047.2021.1919004%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3DGP2GMVYF%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Anti-tumor%20effect%20of%20trametinib%20in%20bladder%20cancer%20organoid%20and%20the%20underlying%20mechanism%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mohamed%22%2C%22lastName%22%3A%22Elbadawy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yomogi%22%2C%22lastName%22%3A%22Sato%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takashi%22%2C%22lastName%22%3A%22Mori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuta%22%2C%22lastName%22%3A%22Goto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kimika%22%2C%22lastName%22%3A%22Hayashi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megumi%22%2C%22lastName%22%3A%22Yamanaka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daigo%22%2C%22lastName%22%3A%22Azakami%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tsuyoshi%22%2C%22lastName%22%3A%22Uchide%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryuji%22%2C%22lastName%22%3A%22Fukushima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Toshinori%22%2C%22lastName%22%3A%22Yoshida%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Makoto%22%2C%22lastName%22%3A%22Shibutani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mio%22%2C%22lastName%22%3A%22Kobayashi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuta%22%2C%22lastName%22%3A%22Shinohara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amira%22%2C%22lastName%22%3A%22Abugomaa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masahiro%22%2C%22lastName%22%3A%22Kaneda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hideyuki%22%2C%22lastName%22%3A%22Yamawaki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tatsuya%22%2C%22lastName%22%3A%22Usui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kazuaki%22%2C%22lastName%22%3A%22Sasaki%22%7D%5D%2C%22abstractNote%22%3A%22Bladder%20cancer%20%28BC%29%2C%20a%20main%20neoplasm%20of%20urinary%20tract%2C%20is%20usually%20inoperable%20and%20unresponsive%20to%20chemotherapy.%20As%20a%20novel%20experimental%20model%20for%20muscle-invasive%20BC%2C%20we%20previously%20established%20a%20culture%20method%20of%20dog%20BC%20organoids.%20In%20the%20present%20study%2C%20the%20detailed%20in%20vitro%20and%20in%20vivo%20anti%5Cu2010tumor%20effects%20of%20trametinib%20were%20investigated%20by%20using%20this%20model.%20In%20each%20BC%20organoid%20strain%2C%20epidermal%20growth%20factor%20receptor%20%28EGFR%29%5C%2FERK%20signaling%20was%20upregulated%20compared%20with%20normal%20bladder%20cells.%20Trametinib%20even%20at%20a%20low%20concentration%20inhibited%20the%20cell%20viability%20of%20BC%20organoids%20and%20the%20activation%20of%20ERK%20through%20decreasing%20expression%20of%20c-Myc%2C%20ELK1%2C%20SIK1%2C%20and%20PLA2G4A.%20Trametinib%20arrested%20cell%20cycle%20of%20BC%20with%20few%20apoptosis.%20Dual%20treatment%20of%20BC%20organoids%20with%20trametinib%20and%20YAP%20inhibitor%2C%20verteporfin%20extremely%20inhibited%20the%20cell%20viability%20with%20apoptosis%20induction.%20Moreover%2C%20trametinib%20induced%20basal%20to%20luminal%20differentiation%20of%20BC%20organoids%20by%20upregulating%20luminal%20markers%20and%20downregulating%20basal%20ones.%20In%20vivo%2C%20trametinib%20decreased%20the%20tumor%20growth%20of%20BC%20organoids%20in%20mice%20and%20the%20xenograft-derived%20organoids%20from%20trametinib-administered%20mice%20showed%20enhanced%20sensitivity%20to%20carboplatin%20due%20to%20MSH2%20upregulation.%20Our%20data%20suggested%20a%20new%20strategy%20of%20trametinib-YAP%20inhibitor%20or%20trametinib-carboplatin%20combination%20as%20a%20promising%20treatment%20of%20BC.%22%2C%22date%22%3A%22May%2026%2C%202021%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1080%5C%2F15384047.2021.1919004%22%2C%22ISSN%22%3A%221538-4047%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F15384047.2021.1919004%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-05-27T18%3A28%3A57Z%22%7D%7D%5D%7D
Elbadawy, M., Sato, Y., Mori, T., Goto, Y., Hayashi, K., Yamanaka, M., Azakami, D., Uchide, T., Fukushima, R., Yoshida, T., Shibutani, M., Kobayashi, M., Shinohara, Y., Abugomaa, A., Kaneda, M., Yamawaki, H., Usui, T., & Sasaki, K. (2021). Anti-tumor effect of trametinib in bladder cancer organoid and the underlying mechanism. Cancer Biology & Therapy, 0(0), 1–15. https://doi.org/10.1080/15384047.2021.1919004 Cite
